Home > News > The Profitable World of Targeted Drug Delivery
April 23rd, 2010
The Profitable World of Targeted Drug Delivery
Abstract:
In the classic 1966 science fiction movie Fantastic Voyage, a submarine equipped with medical devices was miniaturized to create a tiny, nanotech vessel. The fictional submarine, named Proteus, transported scientists through the human body to repair a blood clot in an important diplomat's brain.
Today, researchers are working on nanotechnologies that do essentially the same thing, though without a miniaturized Raquel Welch. Like the fictional craft Proteus, however, these remarkable "nanovesicles" can travel to specific sites in the body to deliver lifesaving therapies.
This is a truly disruptive technology that will eventually change the way virtually all drugs are delivered to the body. In the process, it will allow lower and safer doses, saving money both by cutting the amount of product needed and by reducing side effects and their many medical and legal costs. These savings will power this industry and provide early investors in these technologies truly transformational profits.
Source:
howestreet.com
Bookmark:
| Related News Press |
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
New-Contracts/Sales/Customers
Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center: New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes March 25th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020
GREENWAVES TECHNOLOGIES Announces Next Generation GAP9 Hearables Platform Using GLOBALFOUNDRIES 22FDX Solution October 16th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||